Steve Killmeyer

Prior to Aimmune, Steve spent over five years in the Deloitte Life Science M&A Finance practice where he worked with Fortune 500 clients on M&A growth strategy and integration. His integration work focused on standing up the core Finance infrastructure and processes for private equity acquisitions.

Prior to Deloitte, Steve worked as a healthcare investor at a startup private equity fund, HealthCor Partners, and as a healthcare investment banker at Merrill Lynch.

Steve holds a Master of Business Administration from The Wharton School at the University of Pennsylvania, and a Bachelor of Science in Finance from Carnegie Mellon University.